Trading Radar for 8/11: NVIDIA (NVDA), Macy's (M), Himax (HIMX), Nordstrom (JWN), voxeljet (VJET) Report
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Nasdaq tumbles, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
RBC Capital Reiterates Outperform on Alibaba (BABA) Following Strong 1Q Results
August 12, 2016 10:20 AM EDTRBC Capital reiterated an Outperform rating on Alibaba (NYSE: BABA), and raised the price target to $110.00 (from $105.00), following the company's 1Q earnings report. BABA reported revenues of 32.15B RMB, beating the Street's 30.0B estimate. Non-GAAP EPS of 4.90 RMB also beat the Street at 4.56 RMB.... More
Brean Capital Raises Price Target on Alibaba (BABA) to $115 on Strong 1Q Results
August 12, 2016 9:49 AM EDTBrean Capital reiterated a Buy rating on Alibaba (NYSE: BABA), and raised the price target to $115.00 (from $100.00), following the company's 1Q earnings report. Revenue came in at RMB 32.2bn, exceeding consensus estimates of RMB 30.1bn. Adjusted EPS came in at $0.74, exceeding consensus of $0.62 on operating leverage from higher core ecommerce revenue.
Analyst Fawne Jiang commented, "BABA reported strong FY1Q17... More
Oppenheimer Adjusts Estimates on Sunrun (RUN); Reiterates Outperform
August 12, 2016 9:45 AM EDTOppenheimer reiterated an Outperform rating on Sunrun (NASDAQ: RUN), and raised the price target to $9.00 (from $8.00), following the company's 2Q earnings report. Oppenheimer adjusted revenue and GAAP EPS estimates to $143M and ($0.25), from $130.2M and ($0.34) for the 3Q, versus the consensus estimates of $132M and... More
Oppenheimer Raises price Target on Alibaba (BABA) to $115 Following 1Q
August 12, 2016 9:38 AM EDTOppenheimer reiterated an Outperform rating on Alibaba (NYSE: BABA), and raised the price target to $115.00 (from $110.00), following the company's 1Q earnings report.
Analyst Jason Helfstein commented, "Raising price target from $110 to $115 on extraordinary F1Q:17 results, with GMV/ revenue/EBITDA exceeding consensus by... More
UBS Remains Sidelined on Macy's (M) Following 2Q Beat and Announced Store Closures
August 12, 2016 9:11 AM EDTUBS reiterated a Neutral rating on Macy's (NYSE: M), and raised the price target to $40.00 (from $33.00), following the company's 2Q earnings report and announced closures. Macy's reported EPS of $0.54 ahead of the Street's $0.45 estimate. Macy's will close 100 doors near year-end. A ~$1B sales reduction (-4%).... More
UBS Raises Price Target on Kohl's Corp. (KSS) to $44 Following 2Q EPS Beat
August 12, 2016 9:03 AM EDTUBS reiterated a Neutral rating on Kohl's Corp. (NYSE: KSS), and raised the price target to $44.00 (from $37.00), following the company's 2Q earnings report. KSS reported EPS of $1.22, ahead of the Street's $1.03 estimate.
Analyst Michael Binetti commented, "KSS reported 2Q EPS of $1.22 (UBSe:... More
Oppenheimer Remains Sidelined on Himax Technologies (HIMX) Following Positive 2Q
August 12, 2016 8:57 AM EDTOppenheimer reiterated a Perform rating on Himax Technologies (NASDAQ: HIMX) following the company's 2Q earnings report. Total 2Q16 revenues were up 12% Y/Y. Small-/mid-sized driver sales up 9% Y/Y and 14% Q/Q. HIMX reported non-GAAP EPS of $0.12 vs. the Street's $0.10.
Analyst Andrew Uerkwitz... More
Wedbush Raises Price Target on Alibaba (BABA) to $90 Following 1Q
August 12, 2016 8:44 AM EDTWedbush reiterated a Neutral rating on Alibaba (NYSE: BABA), and raised the price target to $90.00 (from $80.00), following the company's 1Q earnings report. Revenue grew to $4.84 billion and topped consensus of $4.54 billion. Adjusted EBITDA of $2.1 billion topped consensus of $2.0 billion on better-than-expected revenue.... More
Jefferies Reiterates Buy on Kohl's Corp. (KSS) Following 2Q and Macy's Announced Closures
August 12, 2016 8:38 AM EDTJefferies reiterated a Buy rating on Kohl's (NYSE: KSS), and raised the price target to $51.00 (from $47.00), following the company's 2Q earnings report and Macy's closure announcements. Macy's announced plans to close about 100 stores. This could have a positive effect on KSS comp... More
Piper Jaffray Cuts Price Target on Materialise NV (MTLS) Following Mixed 2Q
August 12, 2016 8:31 AM EDTPiper Jaffray maintained an Overweight rating on Materialise NV (NASDAQ: MTLS), and cut the price target to $8.50 (from $9.00), following the company's 2Q earnings report. Revenues grew 11.4% Y/Y to 27.6M, which was roughly 0.9M below the Street at 28.5M. Pro Forma EPS of (0.01) was in-line with Street expectations.
Analyst Troy Jensen commented,... More
Piper Jaffray Raises Price Target on Brinker International (EAT) to $50 Following 4Q
August 12, 2016 8:08 AM EDTPiper Jaffray reiterated a Neutral rating on Brinker International (NYSE: EAT), and raised the price target to $50.00 (from $49.00), following the company's 4Q earnings report. Fourth-quarter operating earnings increased 31.2% y/y to $1.24 per share, in-line with the Street's $1.23. Unchanged FY17 estimates of... More
FBR Capital Remains Bullish on Seres Therapeutics (MCRB); Says Sell-Off is 'Overdone'
August 12, 2016 8:01 AM EDTFBR Capital maintained an Outperform rating on Seres Therapeutics (NASDAQ: MCRB), and cut the price target to $23.00 (from $43.00), following the company's recent sell-off.
Analyst Vernon Bernardino commented, "We look at MCRB as the leader in advancing the microbiome approach to treating chronic... More
Piper Jaffray Raises Price Target on Planet Fitness (PLNT) to $23 Following 2Q Report
August 12, 2016 7:50 AM EDTPiper Jaffray reiterated an Overweight rating on Planet Fitness (NYSE: PLNT), and raised the price target to $23.00 (from $21.00), following the company's 2Q earnings report. System-wide comparable sales grew 7.6% during the quarter, better than the 5.9% the street was expecting and an increase from 6.8% in Q1.... More
Baird Reiterates Outperform on Itron (ITRI) Following Solid 1Q Report - PT to 47
August 12, 2016 7:10 AM EDTBaird reiterated an Outperform rating and $47.00 price target on Itron (NASDAQ: ITRI) following the company's 1Q earnings report. ITRI reported revenue of $497.6M vs. consensus estimates of $450.8M. Non-GAAP EPS was $0.44 vs. consensus estimates of $0.32.
Analyst Ben Kallo commented, "Q1 beat our... More
RBC Capital Remains Sidelined on Brinker International (EAT) Following 4Q - PT to $55
August 12, 2016 7:02 AM EDTRBC Capital reiterated a Sector Perform rating on Brinker International (NYSE: EAT), and raised the price target to $55.00 (from $49.00), following the company's 4Q earnings report. RBC's FY17 EPS estimates remain unchanged at (-3.6% YOY) and is within the company's $3.40 to $3.50 guidance range.
Analyst... More